TickerFacts.

Ludwig Enterprises, Inc. (LUDG): Operating Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$1.77M
Year ended 2025-12-31
-$1.81M
Trailing 12 months to 2026-03-31
$560.5K2022-12-31: $560.5K2023-12-31: -$1.38M2024-12-31: -$1.30M2025-12-31: -$1.77M-$1.77M
2022-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$1.77Mn/m2026-03-16, From 2025-01-01
2024-12-31-$1.30Mn/m2026-03-16, From 2024-01-01
2023-12-31-$1.38Mn/c2025-03-31, From 2023-01-01
2022-12-31$560.5Kn/a2024-04-16, From 2022-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Ludwig Enterprises, Inc. (LUDG)2025-12-31-$1.77Mn/m
First Choice Healthcare Solutions, Inc. (FCHS)2025-12-31-$2.67Mn/m
BioNexus Gene Lab Corp (BGLC)2025-12-31-$2.97Mn/m
Aclarion, Inc. (ACON)2025-12-31-$7.05Mn/m
YD Bio Ltd (YDES)2025-12-31-$5.27Mn/m
American Shared Hospital Services (AMS)2025-12-31-$3.59Mn/m
Exagen Inc. (XGN)2025-12-31-$14.07Mn/m
Biodesix Inc (BDSX)2025-12-31-$27.87Mn/m
Freenome, Inc. (FRNM)2025-12-31-$2.98Mn/a

Compare LUDG, FCHS, BGLC, ACON side by side · Screen every company in Services-Medical Laboratories ↗